A new systematic review shows that nasal spray adrenaline (via liquid or powder sprays) can be as fast or faster than injections for treating anaphylaxis, a possible needle-free alternative to EpiPen®.
Open Access Government looks into the National Institute of General Medical Sciences (NIGMS)’s Biochemistry and Bio-related Chemistry Branch, and its current research areas and priorities.
Researchers from the University of North Carolina and NC State have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise, leading the way for new diabetes treatment.
Doctor Allon Barsam, consultant eye surgeon and founder of Ophthalmic Consultants of London, calls attention to the unexplored devastation behind the NHS virus frontlines.
Dr Juliana Bowles, School of Computer Science, University of St Andrews, discusses how to tackle polypharmacy and multimorbidities with computational techniques.
Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.
Sandra Greenbank, Nutritional Therapist & creator of the Corporate Fertility Policy, explores the impact that COVID-19 has had on those struggling with fertility and how employers can offer support.
Skin conditions often get worse when we are stressed – for example, during the COVID-19 pandemic. Have you just been diagnosed with acne rosacea? Are there any tips or tricks on how to manage it? Here, Dr Deborah Lee, Dr Fox Online Pharmacy, explains everything you need to know.
Scientists at TCS designed novel chemical compounds using AI that can inhibit the 3CL protease of SARS-CoV-2, which is responsible for viral replication. Ananth Krishnan, Chief Technology Office, TCS, discusses the research here.
Innovative technologies have the power to entirely transform the NHS, mitigating the workforce challenges that it faces and transforming the patient experience, whilst improving outcomes, Justin Hall, Vice President and General Manager at iRhythm, discusses here.
